Conversely, cluster of differentiation 4 (CD4)+Foxp3+ regulatory T cells (Tregs) act as immunosuppressors in antitumor immunity, typically accumulating in the TME of CRC patients and entering peripheral blood as the tumor progresses, inducing immune tolerance and promoting immune evasion [14]. The gene discussed is CD4; the disease is neoplasm.